Go Deep
Yarrow Bioscience Inc
Yarrow Bioscience Inc Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 18,733 | — | 8.44 | 0.00 | 1,894.30 |
| Oct 2026 | 19,270 | — | 7.72 | 0.00 | 1,734.23 |
| Oct 2026 | 16,940 | — | 8.43 | 0.00 | 1,894.43 |
| Oct 2026 | 16,867 | — | 8.52 | 0.00 | 1,916.24 |
| Oct 2026 | 16,879 | — | 8.51 | 0.00 | 1,907.72 |
| Oct 2026 | 17,060 | — | 8.27 | 0.00 | 1,850.06 |
Yarrow Bioscience Inc Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 97,000.0 | 0.0 | 0.0 | 69,000.0 |
| Net Profit | -3,007,000.0 | -2,745,000.0 | -70,994,000.0 | -5,755,000.0 |
| EPS | -175.5 | -160.0 | -4,137.2 | -336.5 |
Yarrow Bioscience Inc Revenue & Profit
Annual financial data isn't available for this company right now.
Yarrow Bioscience Inc Balance Sheet
| Line Item | Dec 2025 |
|---|---|
| Total Assets | 100,407,000.0 |
| Total Liabilities | 71,547,000.0 |
| Total Equity | 28,860,000.0 |
Owes vs Owns
Yarrow Bioscience Inc owed $0.07 for every $1 it owned in Jun 2026, down from $0.71 in Dec 2025.
| Period | Jun 2026 | Dec 2025 |
|---|---|---|
| Owes vs Owns | 0.07× | 0.71× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Yarrow Bioscience Inc Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 99.6%
How it's funded — Dec 2025
Payables 1.5%Other liabilities 69.7%Shareholders' equity 28.7%
| Line Item | Dec 2025 |
|---|---|
| Assets | |
| Cash & short-term investments | 100.0 |
| Receivables | 0.0 |
| Inventory | 0.0 |
| Fixed assets (tangible) | 0.0 |
| Intangible assets | 0.0 |
| Long-term investments | 0.0 |
| Other assets | 0.4 |
| Liabilities & equity | |
| Short-term debt | 0.0 |
| Long-term debt | 0.0 |
| Payables | 1.5 |
| Other liabilities | 70.0 |
| Shareholders' equity | 28.9 |
| Net tangible assets | 28.9 |
Yarrow Bioscience Inc Cash Flow
Cash flow data isn't available for this company right now.